bFGF and TGFbeta1 growth factors, inflammatory markers (IL-6, TNF-alpha, CRP) and advanced glycation end-products (AGE, RAGE) in patients with ischemic heart disease and type 2 diabetes mellitus
Aims. To evaluate plasma levels of transforming growth factor beta (TGFbeta1), basic fibroblast growth factor (bFGF), markers for nonspecific inflammatory process (interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha), C-reactive protein (CRP)) and their putative correlation with advanced g...
Guardado en:
Autores principales: | Ekaterina Vladimirovna Ivannikova, Konstantin Vladimirovich Melkozerov, Victor Yur'evich Kalashnikov, Sergey Anatol'evich Terekhin, Irina Vladimirovna Kononenko, Olga Mikhailovna Smirnova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b0fbad2a6514d469b658ef544be064c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ischaemic heart disease in patients with diabetes mellitus and critical lower limb ischemia
por: Konstantin Vladimirovich Melkozerov, et al.
Publicado: (2012) -
Interventional cardiology and diabetes mellitus: age of effective coronary heart disease treatment
por: Victor Yur'evich Kalashnikov, et al.
Publicado: (2011) -
Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
por: Marina Sergeevna Michurova, et al.
Publicado: (2014) -
The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
por: Ekaterina Vladimirovna Ivannikova, et al.
Publicado: (2014) -
Myocardial revascularization in diabetic patients presenting with critical limbischemia
por: Ivan Ivanovich Dedov, et al.
Publicado: (2010)